Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia

NCT: NCT07032428 · NOT_YET_RECRUITING

NCT IDNCT07032428
StatusNOT_YET_RECRUITING
Start Date2026-07-15
Completion2028-07-30
SponsorMagnetic Tides (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this proposal is to provide a first assessment of the efficacy of our innovative non-invasive brain stimulation system, kTMP, in the treatment of anhedonia in MDD.

Frequently Asked Questions

What is Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia?

Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia is a clinical trial registered under NCT07032428. Current status: NOT_YET_RECRUITING.

What is the status of NCT07032428?

The current status of NCT07032428 (Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia) is: NOT_YET_RECRUITING.

When did Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia start?

Efficacy of kTMP, a Novel Non-invasive Brain Stimulation Method, for the Treatment of Anhedonia started on 2026-07-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑